Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines and treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. The company was founded by William R. Gargiulo, Jr. and O. B. Parrish in 1971 and is headquartered in Miami, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
20
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Veru Inc market cap is $35.98M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Veru Inc 52 week high is $7.33 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Veru Inc 52 week low is $1.93 as of November 21, 2026.
Veru Inc stock price today is $1.94.
Veru Inc stock price yesterday was $2.11.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Veru Inc's P/E ratio is -3.18.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Veru Inc P/B ratio is 1.1657.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Veru Inc 50-day moving average is $2.31.